China Shineway Pharmaceutical Group Limited Cash Flow Quality Index
China Shineway Pharmaceutical Group Limited cash flow quality index. China Shineway Pharmaceutical Group Limited (C1S) has a Cash Flow Quality Index of 0.65x as of June 2023. Operating cash flow of €160.69 Million is below net income of €245.73 Million, suggesting accrual-heavy earnings not yet converted to cash. See C1S financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of China Shineway Pharmaceutical Group Limited (2013–2025)
Cash flow quality index of China Shineway Pharmaceutical Group Limited from 2013 to 2025. Historical Cash Flow Quality Index for China Shineway Pharmaceutical Group Limited across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of China Shineway Pharmaceutical Group Limi to assess how comfortably operating cash covers total debt obligations.
China Shineway Pharmaceutical Group Limited Cash Flow Quality Index by Year (2013–2025)
China Shineway Pharmaceutical Group Limited cash flow quality index by year from 2013 to 2025. Year-by-year earnings quality comparison for China Shineway Pharmaceutical Group Limited. For the full cash flow conversion analysis, see cash flow conversion of China Shineway Pharmaceutical Group Limi.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | €1.17 Billion | €949.95 Million | ▲ +7.6% |
| 2024 | 1.15x | €963.13 Million | €840.05 Million | ▲ +19.2% |
| 2023 | 0.96x | €932.63 Million | €969.51 Million | ▼ -37.3% |
| 2022 | 1.54x | €1.11 Billion | €722.77 Million | ▲ +21.5% |
| 2021 | 1.26x | €703.15 Million | €556.67 Million | ▼ -41.6% |
| 2020 | 2.16x | €638.57 Million | €295.03 Million | ▲ +195.9% |
| 2019 | 0.73x | €368.00 Million | €503.15 Million | ▼ -30.5% |
| 2018 | 1.05x | €532.59 Million | €505.88 Million | ▼ -3.1% |
| 2017 | 1.09x | €490.65 Million | €451.55 Million | ▼ -12.7% |
| 2016 | 1.24x | €733.53 Million | €589.20 Million | ▲ +10.0% |
| 2015 | 1.13x | €744.71 Million | €657.91 Million | ▲ +3.2% |
| 2014 | 1.10x | €773.16 Million | €704.77 Million | ▲ +44.3% |
| 2013 | 0.76x | €519.89 Million | €683.65 Million | — |